Pepscan and Tibotec sign peptides deal

September 15, 2010
Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec

Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …

FDA warns BMS over manufacturing plant in Puerto Rico

September 15, 2010
Manufacturing and Production BMS, FDA, GMP, Puerto Rico

A plant operated by Bristol-Myers Squibb in Puerto Rico has been cited by the US Food and Drug Administration for …

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

Boehringer Ingelheim Facebook picture

Digital Pharma: Boehringer gets social with Facebook

September 14, 2010
Medical Communications Boehringer, Digital Pharma blog, Facebook

Boehringer Ingelheim is looking for fans on Facebook and wants its employees to be thought of as “superheroes, only with …

Positive results for irritable bowel syndrome drug

September 14, 2010
Research and Development Almirall, IBS, linaclotide

A new treatment for patients with irritable bowel syndrome with constipation has produced promising results in a phase III trial. …

iPhone app is download hit for Doctors.net.uk

September 14, 2010
Medical Communications Doctors.net.uk, doctors, iphone, tala, tim ringrose

An app launched by Doctors.net.uk in response to a surge in the number of doctors signing up for iPhones, has …

Future of Roche diabetes trial uncertain

September 14, 2010
Research and Development GLP-1, Roche, taspoglutide

Roche has admitted it does not know when phase III trials of the investigational type II diabetes drug taspoglutide will …

Growth slowdown predicted for pharma packaging

September 14, 2010
Manufacturing and Production packaging, pharma packaging

New regulatory requirements in the US are driving growth in the country’s pharmaceutical packaging market, according to market research firm …

Novasep appoints new supervisory board chairman

September 14, 2010
Manufacturing and Production Novasep, appointment, manufacturing and production

French contract manufacturing firm Novasep has appointed Bernard Dubois to its top management team. Most recently a consultant, Bernard formerly …

Genzyme planning 1,000 job cuts

September 14, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, job cuts

Genzyme has said it intends to cut back its workforce by around 1,000 over the next 15 months in order …

GSK launches global joint pain education programme

September 13, 2010
Medical Communications chronic pain, disease awareness campaigns, osteoarthritis

GlaxoSmithKline has launched a global education programme to help sufferers from musculoskeletal conditions such as arthritis to self-manage pain in …

Zactima extends progression free survival in other thyroid cancers

September 13, 2010
Research and Development thyroid cancer, zactima

New data suggests patients with the more common forms of thyroid cancer respond to AstraZeneca’s Zactima. The drug has already …

NICE won’t approve Abilify without more data

September 13, 2010
Sales and Marketing Abilify, BMS, NICE

NICE is unlikely to approve Bristol-Myers Squibb’s schizophrenia drug Abilify unless the company can provide more data on its clinical …

Countdown to Launch

September 13, 2010
Sales and Marketing marketing, product launch

When NASA launches a rocket, most of the hard work is already done. The flight itself is relatively short, yet …

Patrick_Hopkinson

BMS appoints UK market access director

September 13, 2010
Sales and Marketing BMS, UK, appointment, sales and marketing

Patrick Hopkinson has joined Bristol-Myers Squibb as director of market access and external affairs in the UK. He joins the …

The Gateway to Local Adoption Series

Latest content